Greg Brace, MBA, is an experienced professional with fifteen years in the Life Science and Pharma/Biotech industries. Currently, they serve as Director of Deal Finance at AstraZeneca, having previously held leadership roles at MilliporeSigma, Stryker Biotech, and Genocea Biosciences, among others. Greg's educational background includes an MBA from The George Washington University and a Master’s in Biology - Biotechnology from the University of Massachusetts at Lowell. Their core competencies encompass relationship management, contract negotiation, and strategic planning, with a mission to drive innovation and growth in fast-paced environments.
This person is not in any teams
This person is not in any offices